These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 705689)

  • 1. The determination of antithrombin III. Comparison of six methods. Effect of oral contraceptive therapy.
    Bounameaux H; Duckert F; Walter M; Bounameaux Y
    Thromb Haemost; 1978 Jun; 39(3):607-15. PubMed ID: 705689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral contraceptive agents and antithrombin III].
    Kamenov V; Nalbanski B
    Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of levenogesterol (Norplant) contraception on coagulation as measured by antithrombin-III levels.
    Pryor JA; Cooper KR; Bass JD; Hampton HL; Rock WA; Morrison JC
    J Miss State Med Assoc; 1996 Oct; 37(10):777-9. PubMed ID: 8908950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased heparin cofactor II levels in women taking oral contraceptives.
    Toulon P; Bardin JM; Blumenfeld N
    Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogen containing oral contraceptives and antithrombin III activity.
    Rákóczi I; Nagy I; Szigetvári I; Losonczy H; Hadnagy J; Gáti I
    Acta Physiol Acad Sci Hung; 1974; 45(3-4):281-6. PubMed ID: 4471272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M; Beck P
    Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
    Mackie IJ; Segal H; Burren T; Gallimore M; Walshe KJ; Robinson G; Machin SJ
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):647-51. PubMed ID: 2133244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of various estrogen treatment schedules on antithrombin III levels.
    Ambrus JL; Ambrus CM; Lillie MA; Browne BJ; Hanson FW; Niswander K; Witul M; Jung OS; Bartfay-Szabo A
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):543-9. PubMed ID: 959656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA; Bonnar J
    Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surveillance of women taking oral contraceptives by determination of antithrombin III].
    Benoit MO; Raichvarg D; Caillens H; Neau C
    Nouv Presse Med; 1979 Feb; 8(7):528-9. PubMed ID: 461171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the activity of antithrombin-III in latent cholestasis. (A clinico-pharmacological study of the relationship between antithrombin-III activity and steroid cholestasis).
    Horváth T; Nagy I; Gógl A
    Acta Med Acad Sci Hung; 1978; 35(2):105-13. PubMed ID: 742337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III levels in Indian women during pregnancy, post-partum and intake of oral contraceptives.
    Toddywalla VS; Virkar KD
    J Obstet Gynaecol India; 1978 Feb; 28(1):52-4. PubMed ID: 689281
    [No Abstract]   [Full Text] [Related]  

  • 19. [Estrogen-therapy in practice. 4. Contraceptives].
    Lauritzen C
    Fortschr Med; 1977 Jun; 95(23):1518-9. PubMed ID: 142060
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.